Mayo, T., Armstrong, A.W., Kircik, L., Silverberg, J., Blauvelt, A., Esdalie, B., Schneider, S., Mark, T., Gooderham, M. and Alexis, A.F. 2022. Efficacy and safety of up to two years of tralokinumab treatment in adults of different racial subgroups with moderate-to-severe atopic dermatitis. SKIN The Journal of Cutaneous Medicine. 6, 6 (Nov. 2022), s74. DOI:https://doi.org/10.25251/skin.6.supp.74.